THE  .AMERICAN 
JOURNAL  OP  PH  ARM  ACT 
The  following  announcement  has  been  issued  by  the  American 
Drug  Manufacturers'  Association : 
"  On  August  28  the  Scientific  Section  of  the  American  Drug 
Manufacturers'  Association  held  a  meeting  at  the  Waldorf-Astoria, 
New  York  City,  at  which  President  Sayre  of  the  A.  Ph.  A.  was  a 
notable  guest. 
"  One  of  the  actions  of  greatest  moment  took  the  form  of  a 
recommendation  that  extracts  of  aconite  leaves  be  deleted  from 
manufacturers'  price  lists  on  the  ground  that  there  is  practically  no 
demand  for  these  troublesome  preparations.  In  connection  with 
the  subject  of  aconite  it  was  also  decided  to  recommend  the  recog- 
nition of  Japanese  aconite  in  the  U.  S.  P.,  but  as  a  separate  drug, 
since  its  constituents  are  somewhat  different.  It  is  thought  that  its 
admission  would  relieve  the  shortage  of  aconitine,  of  which  there  is 
none  available  in  this  country  at  this  time. 
"  Attention  was  also  given  to  the  fact  that  some  of  the  menstrua 
of  the  U.  S.  P.  are  not  entirely  satisfactory  and  that,  as  a  result, 
manufacturers  are  in  many  instances  obliged  to  list  a  formula  pro- 
viding a  special  menstruum  of  their  own  in  addition  to  the  formula 
of  the  U.  S.  P.,  thus  multiplying  to  a  degree  that  is  vexatious  to  both 
manufacturer  and  dealer  the  number  of  preparations  to  be  carried 
in  stock.  With  a  view  to  simplification,  a  subcommittee  was  ap- 
pointed to  collect  the  experience  of  manufacturers  on  unsatisfactory 
menstrua  and  to  endeavor  to  compile  a  simpler  list  of  menstrua  that 
they  will  be  able  to  recommend  to  the  Committee  of  Revision  as 
meeting  the  approval  of  all  manufacturers. 
"  If  the  Executive  Committee  of  the  Association  adopts  a  sug- 
OCTOBER,  igig 
EDITORIAL. 
PHARMACEUTICAL  RESEARCH. 
